Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
IntroductionInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and daytim...
Saved in:
Published in | BMJ open Vol. 10; no. 5; p. e034421 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
18.05.2020
BMJ Publishing Group |
Series | Protocol |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and daytime function in people with insomnia disorder using objective measures. This proof-of-concept study will evaluate the effects of a single dose of an oral cannabis-based medicine on sleep and daytime function in participants with chronic insomnia disorder.Methods and analysisA randomised, crossover, placebo-controlled, single-dose study design will be used to test the safety and efficacy of an oral oil solution (‘ETC120’) containing 10 mg Δ9-tetrahydrocannabinol (THC) and 200 mg cannabidiol (CBD) in 20 participants diagnosed with chronic insomnia disorder. Participants aged 35–60 years will be recruited over an 18-month period commencing August 2019. Each participant will receive both the active drug and matched placebo, in a counterbalanced order, during two overnight study assessment visits, with at least a 1-week washout period between each visit. The primary outcomes are total sleep time and wake after sleep onset assessed via polysomnography. In addition, 256-channel high-density electroencephalography and source modelling using structural brain MRI will be used to comprehensively examine brain activation during sleep and wake periods on ETC120 versus placebo. Next-day cognitive function, alertness and simulated driving performance will also be investigated.Ethics and disseminationEthics approval was received from Bellberry Human Research Ethics Committee (2018-04-284). The findings will be disseminated in a peer-reviewed open-access journal and at academic conferences.Trial registration numberANZCTRN12619000714189. |
---|---|
AbstractList | Introduction Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and daytime function in people with insomnia disorder using objective measures. This proof-of-concept study will evaluate the effects of a single dose of an oral cannabis-based medicine on sleep and daytime function in participants with chronic insomnia disorder.Methods and analysis A randomised, crossover, placebo-controlled, single-dose study design will be used to test the safety and efficacy of an oral oil solution (‘ETC120’) containing 10 mg Δ9-tetrahydrocannabinol (THC) and 200 mg cannabidiol (CBD) in 20 participants diagnosed with chronic insomnia disorder. Participants aged 35–60 years will be recruited over an 18-month period commencing August 2019. Each participant will receive both the active drug and matched placebo, in a counterbalanced order, during two overnight study assessment visits, with at least a 1-week washout period between each visit. The primary outcomes are total sleep time and wake after sleep onset assessed via polysomnography. In addition, 256-channel high-density electroencephalography and source modelling using structural brain MRI will be used to comprehensively examine brain activation during sleep and wake periods on ETC120 versus placebo. Next-day cognitive function, alertness and simulated driving performance will also be investigated.Ethics and dissemination Ethics approval was received from Bellberry Human Research Ethics Committee (2018-04-284). The findings will be disseminated in a peer-reviewed open-access journal and at academic conferences.Trial registration number ANZCTRN12619000714189. IntroductionInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and daytime function in people with insomnia disorder using objective measures. This proof-of-concept study will evaluate the effects of a single dose of an oral cannabis-based medicine on sleep and daytime function in participants with chronic insomnia disorder.Methods and analysisA randomised, crossover, placebo-controlled, single-dose study design will be used to test the safety and efficacy of an oral oil solution (‘ETC120’) containing 10 mg Δ9-tetrahydrocannabinol (THC) and 200 mg cannabidiol (CBD) in 20 participants diagnosed with chronic insomnia disorder. Participants aged 35–60 years will be recruited over an 18-month period commencing August 2019. Each participant will receive both the active drug and matched placebo, in a counterbalanced order, during two overnight study assessment visits, with at least a 1-week washout period between each visit. The primary outcomes are total sleep time and wake after sleep onset assessed via polysomnography. In addition, 256-channel high-density electroencephalography and source modelling using structural brain MRI will be used to comprehensively examine brain activation during sleep and wake periods on ETC120 versus placebo. Next-day cognitive function, alertness and simulated driving performance will also be investigated.Ethics and disseminationEthics approval was received from Bellberry Human Research Ethics Committee (2018-04-284). The findings will be disseminated in a peer-reviewed open-access journal and at academic conferences.Trial registration numberANZCTRN12619000714189. |
Author | Hoyos, Camilla M Vandrey, Ryan Marshall, Nathaniel S Yee, Brendon J Arnold, Jonathon C Suraev, Anastasia Wong, Keith Gordon, Christopher J Irwin, Chris D'Rozario, Angela L Grunstein, Ronald R Bartlett, Delwyn J McGregor, Iain S |
AuthorAffiliation | 9 The University of Sydney, Faculty of Medicine and Health, Discipline of Pharmacology , Sydney , New South Wales , Australia 2 The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics , Sydney , New South Wales , Australia 6 The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery , Sydney , New South Wales , Australia 7 Behavioral Pharmacology Research Unit , Johns Hopkins University , Baltimore , Maryland , USA 3 The University of Sydney, Faculty of Science, School of Psychology , Sydney , New South Wales , Australia 1 Woolcock Institute of Medical Research, Centre for Sleep and Chronobiology , Sydney , New South Wales , Australia 4 The University of Sydney, Brain and Mind Centre , Sydney , New South Wales , Australia 5 RPA-Charles Perkins Centre , Royal Prince Alfred Hospital , Sydney , New South Wales , Australia 8 Menzies Health Institute Queensland, School Allied Health Sciences , Griffith University , Gold Coast , Queensland |
AuthorAffiliation_xml | – name: 2 The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics , Sydney , New South Wales , Australia – name: 1 Woolcock Institute of Medical Research, Centre for Sleep and Chronobiology , Sydney , New South Wales , Australia – name: 4 The University of Sydney, Brain and Mind Centre , Sydney , New South Wales , Australia – name: 9 The University of Sydney, Faculty of Medicine and Health, Discipline of Pharmacology , Sydney , New South Wales , Australia – name: 5 RPA-Charles Perkins Centre , Royal Prince Alfred Hospital , Sydney , New South Wales , Australia – name: 3 The University of Sydney, Faculty of Science, School of Psychology , Sydney , New South Wales , Australia – name: 6 The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery , Sydney , New South Wales , Australia – name: 8 Menzies Health Institute Queensland, School Allied Health Sciences , Griffith University , Gold Coast , Queensland , Australia – name: 7 Behavioral Pharmacology Research Unit , Johns Hopkins University , Baltimore , Maryland , USA |
Author_xml | – sequence: 1 givenname: Anastasia orcidid: 0000-0002-5993-2246 surname: Suraev fullname: Suraev, Anastasia email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia – sequence: 2 givenname: Ronald R surname: Grunstein fullname: Grunstein, Ronald R email: camilla.hoyos@sydney.edu.au organization: RPA-Charles Perkins Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia – sequence: 3 givenname: Nathaniel S surname: Marshall fullname: Marshall, Nathaniel S email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney, New South Wales, Australia – sequence: 4 givenname: Angela L surname: D'Rozario fullname: D'Rozario, Angela L email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Faculty of Science, School of Psychology, Sydney, New South Wales, Australia – sequence: 5 givenname: Christopher J surname: Gordon fullname: Gordon, Christopher J email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney, New South Wales, Australia – sequence: 6 givenname: Delwyn J surname: Bartlett fullname: Bartlett, Delwyn J email: camilla.hoyos@sydney.edu.au organization: Woolcock Institute of Medical Research, Centre for Sleep and Chronobiology, Sydney, New South Wales, Australia – sequence: 7 givenname: Keith surname: Wong fullname: Wong, Keith email: camilla.hoyos@sydney.edu.au organization: RPA-Charles Perkins Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia – sequence: 8 givenname: Brendon J surname: Yee fullname: Yee, Brendon J email: camilla.hoyos@sydney.edu.au organization: RPA-Charles Perkins Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia – sequence: 9 givenname: Ryan surname: Vandrey fullname: Vandrey, Ryan email: camilla.hoyos@sydney.edu.au organization: Behavioral Pharmacology Research Unit, Johns Hopkins University, Baltimore, Maryland, USA – sequence: 10 givenname: Chris surname: Irwin fullname: Irwin, Chris email: camilla.hoyos@sydney.edu.au organization: Menzies Health Institute Queensland, School Allied Health Sciences, Griffith University, Gold Coast, Queensland, Australia – sequence: 11 givenname: Jonathon C surname: Arnold fullname: Arnold, Jonathon C email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Faculty of Medicine and Health, Discipline of Pharmacology, Sydney, New South Wales, Australia – sequence: 12 givenname: Iain S surname: McGregor fullname: McGregor, Iain S email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia – sequence: 13 givenname: Camilla M surname: Hoyos fullname: Hoyos, Camilla M email: camilla.hoyos@sydney.edu.au organization: The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia |
BookMark | eNpdkktu1DAAhiNUREvpCdhYYjMjkeL3JCyQShhopREgUdaWX-l45LFTJ4PUXQ_BAm7DCThET4LTjBAlshQ_Pn9-_U-LgxCDLYrnCJ4iRPgrtd3EzoYSQ1SXkFCK0aPiCENKSw4ZO_inflic9P0G5o-ymjH8pDgkmJLcgkfFr0aGIJUzLnowa96-mwMZDPj9vS4HOyS5vjEp6okJI3J53sxBGxPQ6xSD08CFPm6Dk8C4PiZjE5jd3f5ozj5-WS2Xn-9uf4IhOennr0GX4hB1lozTJUh5obh1vTUvQeeltiqWOoYhRe_HPhN3yttSeRfMPZNibMtcMqRtN0zeZ8XjVvrenuz_x8XX98vL5rxcffpw0ZytSkUYGkpVQ11XLdSKcI4pI3WrsEaSQsttVWlZa4N4KxlDpDIcti1emKpFhiLTMsrJcXExeU2UG9Elt5XpRkTpxH1HTFdCpsFpbwWHcrQyjU1LNaKKL6ziUlmNMYYaZ9ebydXt1NYabfOhpX8gfTgS3FpcxW9igUl-QZIFs70gxeud7QeR71Fb72WwcdcLTCEjkFQVy-iL_9BN3KWQrypThGBcVZxm6nSicq7-7gNBMWZN7LMmxqyJKWvkD0OYzVE |
Cites_doi | 10.1037/1040-3590.7.1.80 10.1111/j.1753-6405.2012.00845.x 10.1016/0165-1781(89)90047-4 10.1002/cbdv.200790150 10.1038/npp.2009.184 10.1111/bph.12944 10.1136/thx.2004.032078 10.1111/j.1479-8425.2010.00481.x 10.1093/sleep/14.6.540 10.1038/37891 10.1016/S1389-9457(00)00065-4 10.1016/j.jpsychires.2016.02.021 10.1016/j.schres.2011.04.017 10.1371/journal.pone.0152473 10.1016/S2215-0366(18)30427-9 10.1016/j.euroneuro.2014.11.014 10.1001/archinternmed.2008.610 10.1093/sleep/zsy047 10.1111/bph.13333 10.1097/01.jcp.0000125688.05091.8f 10.5664/jcsm.26929 10.1186/s12888-018-1623-0 10.1111/j.1476-5381.2010.00790.x 10.1111/jcpt.12179 10.1016/j.cpr.2011.02.004 10.1093/sleep/zsz122 10.1016/j.pnpbp.2008.04.008 10.1016/j.jad.2011.01.011 10.1037/pha0000285 10.1016/j.genhosppsych.2005.07.003 10.5664/jcsm.6616 10.1089/acm.2013.0190 10.1111/bph.14440 10.1016/S1087-0792(03)00042-X 10.1016/j.clinph.2006.03.011 10.1093/sleep/26.3.313 10.1093/sleep/28.11.1457 10.1007/s00216-011-5197-7 10.1007/BF00434408 10.5665/sleep.4012 10.1080/02791072.2019.1626953 10.1016/j.phrs.2017.02.022 10.1080/15402002.2016.1163702 10.1016/j.smrv.2014.02.005 10.1016/j.addbeh.2015.06.032 10.1007/s11325-019-01866-8 10.1016/S0165-0327(02)00072-1 10.1590/1516-4446-2017-0015 10.1016/S0140-6736(07)60033-6 10.1213/ANE.0b013e3181c76f70 10.1016/j.sleep.2005.08.008 10.1111/j.1365-2869.2008.00697.x 10.1007/s11419-016-0330-0 10.1371/journal.pone.0149770 10.1093/sleep/26.8.943 10.1093/sleep/28.1.113 10.1097/00001756-200107200-00018 10.1111/j.1600-0447.1983.tb09716.x 10.1016/j.smrv.2004.02.001 10.1073/pnas.87.5.1932 10.1016/j.clinph.2013.01.018 10.1016/j.brainres.2008.05.048 10.1007/s00213-019-05246-8 10.5664/jcsm.2752 10.1038/sj.ijo.0803272 10.1038/npp.2010.58 10.1016/S0140-6736(11)60750-2 10.1074/jbc.M114.618447 10.1002/gps.4923 10.1111/j.1755-5949.2008.00071.x 10.1177/1403494813481647 10.1007/s11920-017-0775-9 10.1136/bmj.e7586 10.1016/S0006-8993(98)00969-X 10.1111/bph.13250 10.1097/JCP.0000000000000180 10.1007/s13311-015-0387-1 10.1093/jat/bkx012 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 |
DBID | 9YT ACMMV 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.1136/bmjopen-2019-034421 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2044-6055 |
EndPage | e034421 |
ExternalDocumentID | oai_doaj_org_article_60a0e6e5c2df4c14b67eb6abec2220c2 bmjopen |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 3V. 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHF RHI RMJ RPM UKHRP 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-b351t-b90c98f0cb36624539fb2c1a40e6e88ca9cd16fa55138d60ff27d8f1d41df5463 |
IEDL.DBID | RPM |
ISSN | 2044-6055 |
IngestDate | Tue Oct 22 15:11:05 EDT 2024 Tue Sep 17 21:04:13 EDT 2024 Sat Aug 17 00:00:11 EDT 2024 Thu Oct 10 17:24:21 EDT 2024 Tue Nov 26 19:23:11 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b351t-b90c98f0cb36624539fb2c1a40e6e88ca9cd16fa55138d60ff27d8f1d41df5463 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-5993-2246 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239553/ |
PMID | 32430450 |
PQID | 2433228864 |
PQPubID | 2040975 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_60a0e6e5c2df4c14b67eb6abec2220c2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7239553 proquest_miscellaneous_2405303885 proquest_journals_2433228864 bmj_primary_10_1136_bmjopen_2019_034421 |
PublicationCentury | 2000 |
PublicationDate | 20200518 |
PublicationDateYYYYMMDD | 2020-05-18 |
PublicationDate_xml | – month: 5 year: 2020 text: 20200518 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Protocol |
PublicationTitle | BMJ open |
PublicationYear | 2020 |
Publisher | BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Tham, Yilmaz, Alaverdashvili 2019; 176 Ji, Ivers, Savard 2019; 42 Bakas, van Nieuwenhuijzen, Devenish 2017; 119 Morin, LeBlanc, Daley 2006; 7 Morin, Bélanger, LeBlanc 2009; 169 Cousens, DiMascio 1973; 33 Curran, Andrykowski, Studts 1995; 7 Kevin, Allsop, Lintzeris 2017; 35 Ware, Fitzcharles, Joseph 2010; 110 Chan, Tetzlaff, Gøtzsche 2013; 346 Shannon, Opila-Lehman 2016; 20 Bachhuber, Arnsten, Wurm 2019; 51 Okajima, Komada, INOUE 2011; 9 Herkenham, Lynn, Little 1990; 87 Cheung, Bartlett, Armour 2018; 16 Leggett, Sonnega, Lohman 2018; 33 Babson, Sottile, Morabito 2017; 19 Taylor, Lichstein, Durrence 2005; 28 Murillo-Rodriguez, Blanco-Centurion, Sanchez 2003; 26 D'Souza, Cortes-Briones, Creatura 2019; 6 Belleville, Cousineau, Levrier 2011; 31 Hung, Li, Chen 2018; 18 Pertwee 2006; 30 Sanford, Castillo, Gannon 2008; 1222 Todd, Arnold 2016; 173 Parrott, Hindmarch 1980; 71 Padwal, Majumdar 2007; 369 Buysse, Reynolds, Monk 1989; 28 Belendiuk, Babson, Vandrey 2015; 50 Marshall, Neill, Campbell 2005; 60 Schubart, Sommer, van Gastel 2011; 130 de Almondes, Costa, Malloy-Diniz 2016; 77 Mechoulam, Fride, Hanus 1997; 389 Johns 1991; 14 Miller, Valenti, Harrison 2017; 13 Pertwee 2008; 153 Vaughn, Denning, Stuhr 2010; 160 Baglioni, Battagliese, Feige 2011; 135 Vandrey, Herrmann, Mitchell 2017; 41 Riemann, Voderholzer 2003; 76 Sprecher, Riedner, Smith 2016; 11 Bastien, LeBlanc, Carrier 2003; 26 Bastien, Vallières, Morin 2001; 2 Arkell, Lintzeris, Kevin 2019; 236 Russo, Guy, Robson 2007; 4 Bin, Marshall, Glozier 2012; 36 Mendelson, Roth, Cassella 2004; 8 Pava, Makriyannis, Lovinger 2016; 11 Littner, Kushida, Wise 2005; 28 Carney, Harris, Falco 2013; 9 Nicholson, Turner, Stone 2004; 24 Gates, Albertella, Copeland 2014; 18 Hindocha, Freeman, Schafer 2015; 25 Arkell, Kevin, Stuart 2019 Baiardi, Mondini 2019 Murillo-Rodríguez, Cabeza, Méndez-Díaz 2001; 12 Cameron, Watson, Robinson 2014; 34 Kaida, Takahashi, Åkerstedt 2006; 117 Fraser 2009; 15 Bertisch, Pollock, Mittleman 2018; 41 Laprairie, Bagher, Kelly 2015; 172 Perrier, Bertran, Marie 2014; 37 Pearce, Mitsouras, Irizarry 2014; 20 Murillo-Rodríguez 2008; 32 Zigmond, Snaith 1983; 67 Verster, Veldhuijzen, Volkerts 2004; 8 Blessing, Steenkamp, Manzanares 2015; 12 Sivertsen, Øverland, Pallesen 2009; 18 Franzen, Buysse 2008; 10 Bhattacharyya, Morrison, Fusar-Poli 2010; 35 Chagas, Eckeli, Zuardi 2014; 39 Van Reeth, Weibel, Spiegel 2000; 4 McPartland, Duncan, Di Marzo 2015; 172 Elmes, Kaczocha, Berger 2015; 290 Kuhathasan, Dufort, MacKillop 2019; 27 Roth 2007; 3 Murillo-Rodríguez, Sánchez-Alavez, Navarro 1998; 812 Putilov, Donskaya 2013; 124 Schwope, Scheidweiler, Huestis 2011; 401 Morgan, Freeman, Schafer 2010; 35 Martin, Rief, Klaiberg 2006; 28 Morin, Benca 2012; 379 Lallukka, Haaramo, Rahkonen 2013; 41 Linares, Zuardi, Pereira 2019; 41 |
References_xml | – volume: 7 start-page: 80 year: 1995 article-title: Short form of the profile of mood states (POMS-SF): psychometric information publication-title: Psychol Assess doi: 10.1037/1040-3590.7.1.80 contributor: fullname: Studts – volume: 36 start-page: 462 year: 2012 article-title: The burden of insomnia on individual function and healthcare consumption in Australia publication-title: Aust N Z J Public Health doi: 10.1111/j.1753-6405.2012.00845.x contributor: fullname: Glozier – volume: 28 start-page: 193 year: 1989 article-title: The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research publication-title: Psychiatry Res doi: 10.1016/0165-1781(89)90047-4 contributor: fullname: Monk – volume: 4 start-page: 1729 year: 2007 article-title: Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine publication-title: Chem Biodivers doi: 10.1002/cbdv.200790150 contributor: fullname: Robson – volume: 35 start-page: 764 year: 2010 article-title: Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.184 contributor: fullname: Fusar-Poli – volume: 172 start-page: 737 year: 2015 article-title: Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review publication-title: Br J Pharmacol doi: 10.1111/bph.12944 contributor: fullname: Di Marzo – volume: 60 start-page: 427 year: 2005 article-title: Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea publication-title: Thorax doi: 10.1136/thx.2004.032078 contributor: fullname: Campbell – volume: 9 start-page: 24 year: 2011 article-title: A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia publication-title: Sleep Biol Rhythms doi: 10.1111/j.1479-8425.2010.00481.x contributor: fullname: INOUE – volume: 14 start-page: 540 year: 1991 article-title: A new method for measuring daytime sleepiness: the Epworth Sleepiness scale publication-title: Sleep doi: 10.1093/sleep/14.6.540 contributor: fullname: Johns – volume: 389 start-page: 25 year: 1997 article-title: Anandamide may mediate sleep induction publication-title: Nature doi: 10.1038/37891 contributor: fullname: Hanus – volume: 2 start-page: 297 year: 2001 article-title: Validation of the insomnia severity index as an outcome measure for insomnia research publication-title: Sleep Med doi: 10.1016/S1389-9457(00)00065-4 contributor: fullname: Morin – volume: 77 start-page: 109 year: 2016 article-title: Insomnia and risk of dementia in older adults: systematic review and meta-analysis publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2016.02.021 contributor: fullname: Malloy-Diniz – volume: 130 start-page: 216 year: 2011 article-title: Cannabis with high cannabidiol content is associated with fewer psychotic experiences publication-title: Schizophr Res doi: 10.1016/j.schres.2011.04.017 contributor: fullname: van Gastel – year: 2019 article-title: Detection of Δ9THC in oral fluid following vaporised cannabis with varied cannabidiol (CBD) content: an evaluation of two point‐of‐collection testing devices publication-title: Drug Test Anal contributor: fullname: Stuart – volume: 11 year: 2016 article-title: Endocannabinoid signaling regulates sleep stability publication-title: PLoS One doi: 10.1371/journal.pone.0152473 contributor: fullname: Lovinger – volume: 33 start-page: 355 year: 1973 article-title: (−) δ 9 THC as an hypnotic publication-title: Psychopharmacologia contributor: fullname: DiMascio – volume: 6 start-page: 35 year: 2019 article-title: Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2A single-site randomised controlled trial publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(18)30427-9 contributor: fullname: Creatura – volume: 25 start-page: 325 year: 2015 article-title: Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2014.11.014 contributor: fullname: Schafer – volume: 169 start-page: 447 year: 2009 article-title: The natural history of insomnia: a population-based 3-year longitudinal study publication-title: Arch Intern Med doi: 10.1001/archinternmed.2008.610 contributor: fullname: LeBlanc – volume: 41 year: 2018 article-title: Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep heart health study publication-title: Sleep doi: 10.1093/sleep/zsy047 contributor: fullname: Mittleman – volume: 173 start-page: 53 year: 2016 article-title: Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis publication-title: Br J Pharmacol doi: 10.1111/bph.13333 contributor: fullname: Arnold – volume: 24 start-page: 305 year: 2004 article-title: Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000125688.05091.8f contributor: fullname: Stone – volume: 3 start-page: S7 year: 2007 article-title: Insomnia: definition, prevalence, etiology, and consequences publication-title: J Clin Sleep Med doi: 10.5664/jcsm.26929 contributor: fullname: Roth – volume: 18 year: 2018 article-title: Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study publication-title: BMC Psychiatry doi: 10.1186/s12888-018-1623-0 contributor: fullname: Chen – volume: 160 start-page: 530 year: 2010 article-title: Endocannabinoid signalling: has it got rhythm? publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2010.00790.x contributor: fullname: Stuhr – volume: 39 start-page: 564 year: 2014 article-title: Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series publication-title: J Clin Pharm Ther doi: 10.1111/jcpt.12179 contributor: fullname: Zuardi – volume: 31 start-page: 638 year: 2011 article-title: Meta-Analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety publication-title: Clin Psychol Rev doi: 10.1016/j.cpr.2011.02.004 contributor: fullname: Levrier – volume: 42 year: 2019 article-title: Residual symptoms after natural remission of insomnia: associations with relapse over 4 years publication-title: Sleep doi: 10.1093/sleep/zsz122 contributor: fullname: Savard – volume: 32 start-page: 1420 year: 2008 article-title: The role of the CB1 receptor in the regulation of sleep publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2008.04.008 contributor: fullname: Murillo-Rodríguez – volume: 135 start-page: 10 year: 2011 article-title: Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies publication-title: J Affect Disord doi: 10.1016/j.jad.2011.01.011 contributor: fullname: Feige – volume: 27 start-page: 383 year: 2019 article-title: The use of cannabinoids for sleep: a critical review on clinical trials publication-title: Exp Clin Psychopharmacol doi: 10.1037/pha0000285 contributor: fullname: MacKillop – volume: 28 start-page: 71 year: 2006 article-title: Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population publication-title: Gen Hosp Psychiatry doi: 10.1016/j.genhosppsych.2005.07.003 contributor: fullname: Klaiberg – volume: 13 start-page: 785 year: 2017 article-title: Time trends in the family physician management of insomnia: the Australian experience (2000-2015) publication-title: J Clin Sleep Med doi: 10.5664/jcsm.6616 contributor: fullname: Harrison – volume: 20 start-page: 787 year: 2014 article-title: Discriminating the effects of cannabis sativa and cannabis indica: a web survey of medical cannabis users publication-title: J Altern Complement Med doi: 10.1089/acm.2013.0190 contributor: fullname: Irizarry – volume: 176 start-page: 1455 year: 2019 article-title: Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors publication-title: Br J Pharmacol doi: 10.1111/bph.14440 contributor: fullname: Alaverdashvili – volume: 8 start-page: 7 year: 2004 article-title: The treatment of chronic insomnia: drug indications, chronic use and abuse liability. summary of a 2001 new clinical drug evaluation unit meeting symposium publication-title: Sleep Med Rev doi: 10.1016/S1087-0792(03)00042-X contributor: fullname: Cassella – volume: 117 start-page: 1574 year: 2006 article-title: Validation of the Karolinska sleepiness scale against performance and EEG variables publication-title: Clinical Neurophysiology doi: 10.1016/j.clinph.2006.03.011 contributor: fullname: Åkerstedt – volume: 26 start-page: 313 year: 2003 article-title: Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines publication-title: Sleep doi: 10.1093/sleep/26.3.313 contributor: fullname: Carrier – volume: 28 start-page: 1457 year: 2005 article-title: Epidemiology of insomnia, depression, and anxiety publication-title: Sleep doi: 10.1093/sleep/28.11.1457 contributor: fullname: Durrence – volume: 401 start-page: 1273 year: 2011 article-title: Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry publication-title: Anal Bioanal Chem doi: 10.1007/s00216-011-5197-7 contributor: fullname: Huestis – volume: 71 start-page: 173 year: 1980 article-title: The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review publication-title: Psychopharmacology doi: 10.1007/BF00434408 contributor: fullname: Hindmarch – volume: 37 start-page: 1565 year: 2014 article-title: Impaired driving performance associated with effect of time duration in patients with primary insomnia publication-title: Sleep doi: 10.5665/sleep.4012 contributor: fullname: Marie – volume: 51 start-page: 400 year: 2019 article-title: Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary publication-title: J Psychoactive Drugs doi: 10.1080/02791072.2019.1626953 contributor: fullname: Wurm – volume: 119 start-page: 358 year: 2017 article-title: The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.02.022 contributor: fullname: Devenish – volume: 16 start-page: 1 year: 2018 article-title: To drug or not to drug: a qualitative study of patients' decision-making processes for managing insomnia publication-title: Behav Sleep Med doi: 10.1080/15402002.2016.1163702 contributor: fullname: Armour – volume: 18 start-page: 477 year: 2014 article-title: The effects of cannabinoid administration on sleep: a systematic review of human studies publication-title: Sleep Med Rev doi: 10.1016/j.smrv.2014.02.005 contributor: fullname: Copeland – volume: 50 start-page: 178 year: 2015 article-title: Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users publication-title: Addict Behav doi: 10.1016/j.addbeh.2015.06.032 contributor: fullname: Vandrey – start-page: 1 year: 2019 article-title: Inside the clinical evaluation of sleepiness: subjective and objective tools publication-title: Sleep Breath doi: 10.1007/s11325-019-01866-8 contributor: fullname: Mondini – volume: 76 start-page: 255 year: 2003 article-title: Primary insomnia: a risk factor to develop depression? publication-title: J Affect Disord doi: 10.1016/S0165-0327(02)00072-1 contributor: fullname: Voderholzer – volume: 41 start-page: 9 year: 2019 article-title: Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test publication-title: Braz J Psychiatry doi: 10.1590/1516-4446-2017-0015 contributor: fullname: Pereira – volume: 369 start-page: 71 year: 2007 article-title: Drug treatments for obesity: orlistat, sibutramine, and rimonabant publication-title: Lancet doi: 10.1016/S0140-6736(07)60033-6 contributor: fullname: Majumdar – volume: 110 start-page: 604 year: 2010 article-title: The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial publication-title: Anesth Analg doi: 10.1213/ANE.0b013e3181c76f70 contributor: fullname: Joseph – volume: 153 start-page: 199 year: 2008 article-title: The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin publication-title: Br J Clin Pharmacol contributor: fullname: Pertwee – volume: 7 start-page: 123 year: 2006 article-title: Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors publication-title: Sleep Med doi: 10.1016/j.sleep.2005.08.008 contributor: fullname: Daley – volume: 18 start-page: 122 year: 2009 article-title: Insomnia and long sleep duration are risk factors for later work disability. The Hordaland health study publication-title: J Sleep Res doi: 10.1111/j.1365-2869.2008.00697.x contributor: fullname: Pallesen – volume: 35 start-page: 33 year: 2017 article-title: Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal publication-title: Forensic Toxicol doi: 10.1007/s11419-016-0330-0 contributor: fullname: Lintzeris – volume: 4 start-page: 201 year: 2000 article-title: Interactions between stress and sleep: from basic research to clinical situations publication-title: Sleep Med Rev contributor: fullname: Spiegel – volume: 10 year: 2008 article-title: Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications publication-title: Dialogues Clin Neurosci contributor: fullname: Buysse – volume: 11 year: 2016 article-title: High resolution topography of age-related changes in non-rapid eye movement sleep electroencephalography publication-title: PLoS One doi: 10.1371/journal.pone.0149770 contributor: fullname: Smith – volume: 26 start-page: 943 year: 2003 article-title: Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study publication-title: Sleep doi: 10.1093/sleep/26.8.943 contributor: fullname: Sanchez – volume: 28 start-page: 113 year: 2005 article-title: Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test publication-title: Sleep doi: 10.1093/sleep/28.1.113 contributor: fullname: Wise – volume: 12 start-page: 2131 year: 2001 article-title: Anandamide-Induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor publication-title: Neuroreport doi: 10.1097/00001756-200107200-00018 contributor: fullname: Méndez-Díaz – volume: 67 start-page: 361 year: 1983 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x contributor: fullname: Snaith – volume: 8 start-page: 309 year: 2004 article-title: Residual effects of sleep medication on driving ability publication-title: Sleep Med Rev doi: 10.1016/j.smrv.2004.02.001 contributor: fullname: Volkerts – volume: 87 start-page: 1932 year: 1990 article-title: Cannabinoid receptor localization in brain publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.87.5.1932 contributor: fullname: Little – volume: 124 start-page: 1346 year: 2013 article-title: Construction and validation of the EEG analogues of the Karolinska sleepiness scale based on the Karolinska drowsiness test publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2013.01.018 contributor: fullname: Donskaya – volume: 1222 start-page: 141 year: 2008 article-title: Cannabinoids and hamster circadian activity rhythms publication-title: Brain Res doi: 10.1016/j.brainres.2008.05.048 contributor: fullname: Gannon – volume: 236 start-page: 2713 year: 2019 article-title: Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition publication-title: Psychopharmacology doi: 10.1007/s00213-019-05246-8 contributor: fullname: Kevin – volume: 9 start-page: 567 year: 2013 article-title: The relation between insomnia symptoms, mood, and rumination about insomnia symptoms publication-title: J Clin Sleep Med doi: 10.5664/jcsm.2752 contributor: fullname: Falco – volume: 30 start-page: S13 year: 2006 article-title: The pharmacology of cannabinoid receptors and their ligands: an overview publication-title: Int J Obes doi: 10.1038/sj.ijo.0803272 contributor: fullname: Pertwee – volume: 35 start-page: 1879 year: 2010 article-title: Cannabidiol attenuates the appetitive effects of delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.58 contributor: fullname: Schafer – volume: 379 start-page: 1129 year: 2012 article-title: Chronic insomnia publication-title: The Lancet doi: 10.1016/S0140-6736(11)60750-2 contributor: fullname: Benca – volume: 290 start-page: 8711 year: 2015 article-title: Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) publication-title: J Biol Chem doi: 10.1074/jbc.M114.618447 contributor: fullname: Berger – volume: 33 start-page: 1265 year: 2018 article-title: The association of insomnia and depressive symptoms with all-cause mortality among middle-aged and old adults publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.4923 contributor: fullname: Lohman – volume: 15 start-page: 84 year: 2009 article-title: The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD) publication-title: CNS Neurosci Ther doi: 10.1111/j.1755-5949.2008.00071.x contributor: fullname: Fraser – volume: 41 start-page: 516 year: 2013 article-title: Joint associations of sleep duration and insomnia symptoms with subsequent sickness absence: the Helsinki health study publication-title: Scand J Public Health doi: 10.1177/1403494813481647 contributor: fullname: Rahkonen – volume: 19 year: 2017 article-title: Cannabis, cannabinoids, and sleep: a review of the literature publication-title: Curr Psychiatry Rep doi: 10.1007/s11920-017-0775-9 contributor: fullname: Morabito – volume: 346 year: 2013 article-title: Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials publication-title: BMJ doi: 10.1136/bmj.e7586 contributor: fullname: Gøtzsche – volume: 812 start-page: 270 year: 1998 article-title: Anandamide modulates sleep and memory in rats publication-title: Brain Res doi: 10.1016/S0006-8993(98)00969-X contributor: fullname: Navarro – volume: 172 start-page: 4790 year: 2015 article-title: Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor publication-title: Br J Pharmacol doi: 10.1111/bph.13250 contributor: fullname: Kelly – volume: 34 start-page: 559 year: 2014 article-title: Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0000000000000180 contributor: fullname: Robinson – volume: 20 start-page: 108 year: 2016 article-title: Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report publication-title: Perm J contributor: fullname: Opila-Lehman – volume: 12 start-page: 825 year: 2015 article-title: Cannabidiol as a potential treatment for anxiety disorders publication-title: Neurotherapeutics doi: 10.1007/s13311-015-0387-1 contributor: fullname: Manzanares – volume: 41 start-page: 83 year: 2017 article-title: Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes publication-title: J Anal Toxicol doi: 10.1093/jat/bkx012 contributor: fullname: Mitchell |
SSID | ssj0000459552 |
Score | 2.4040313 |
Snippet | IntroductionInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally,... INTRODUCTIONInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally,... Introduction Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally,... |
SourceID | doaj pubmedcentral proquest bmj |
SourceType | Open Website Open Access Repository Aggregation Database Publisher |
StartPage | e034421 |
SubjectTerms | Cannabidiol Clinical trials Electroencephalography Insomnia Pharmacology and Therapeutics Tetrahydrocannabinol THC |
SummonAdditionalLinks | – databaseName: BMJ Open Access Journals dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NitRAEG5kBfEi_uLoKi0I7oCNSf-l29tunGUQdxGchfUU-ifNjswmojMHb_sQHvRtfAIfYp_EqiQOm4Mg5NSpFJ181V3V6a6vCHkehQ7CaM2S0RmDCU8xL6JjXtlojUw8ddydR8d6fiLfnqrTK8nq4x38XOhX_vwTFpICODHdRkiJaePXeQELGzToj4vtLxWITqzqauzwTEoGgboaeIb-oQf8CbQObP2jEHN8QPKKxzm8TW4NoSLd77G9Q67VzV1y42jYDL9HfpWuaZxfxmW7onvlwZspdU2kv79btq5B4dm3CN6pl2lQZDEvpxSCVBp6RlyKmV_nzdLROHBw0r3Lix_l_vGHd7PZ-8uLn7Qr6jF9TZHOoQWb6R53FBxcbMFC6viSdqe6fMuGQ-8rbIvtxq9q5ldIxogyEJ8nBlfosyR7vffJyeFsUc7ZUJAB8FP5mnmbBWtSFrzQmkslbPI85E5mta6NCc6GmOvksGiMiTpLiRfRpDzKPCbk3X9Adpq2qR8SKg30DcsDei0kqLRJgV0oV6haJGXthLwAaKrPPeVG1S1VhK4GECsEsepBnJADhG8rinzZXQMYUTUMv0pnDvuoAo9Jhlx6jbVgHBgwxEdZ4BOy-xf8ahjEXyuO3G7cGC0n5Nn2Nnxc3FNxTd1uUAZmMWTUURNSjIxm1KHxnWZ51hF5F1yAwYpH__2uj8lNjut9ZI81u2Rn_WVTP4GgaO2fdkPhD33YC1Q priority: 500 providerName: BMJ Publishing Group Ltd – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagB8QFlT8RKMhISHQloib-W5tbG7ZaIVoh0Uq9Rf6J1UXbBJXdA7c-BAd4G56Ah-iTMBOHanPigpSTM3Ecz-fxOB5_Q8irwJXnWqk8alXkYPBk7niwuZMmGC0iiz1359Gxmp-K92fybCPVF8aEJXrg1HF7qrBFoxrpWYjCl8IpzOJh4dUwsxU-Wd-CbSymehsspJGSDTRDJVd77uIz5qMCVOCpHS4EsoPehtKBrH_kYY7jIzcmnMNtcm_wFOl-auF9cqtpH5A7R8Ne-EPyq7Jta90iLLol3a0O3k2obQP9_d3kqwYqPP8WYHJKMi2KnMyrCQUflfpEiEvx4NdFu7A0DBScdPf66ke1f_zpw2z28frqJ-1zekzeUmRz6AAy_eOWwvwWOgBIE97QPqjLdfkQ877EstCt3bLJ3RK5GFEG3POYw-XTIclU7yNyejg7qeb5kI8B1CfLVe5M4Y2OhXdcKSYkN9ExX1qBCtLaW-NDqaLFnDE6qCJGNg06lkGUISLt_mOy1XZt84RQoaFtmB3QKS6gShMlwELaqWx4lMZk5DWopv6SGDfqfqXCVT0osUYl1kmJGTlA9d2IIl12XwAgqgcQ1f8CUUZ2_iq_Hsbw15ohtRvTWomMvLy5DZ2LWyq2bbo1yoARQ0IdmZHpCDSjBo3vtIvznsd7yjiAlD_9H1_wjNxl-CcAeWX1DtlaXa6b5-AurdyLfmT8AWftGRk priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELZokRAXxK9YKMhISHQloib-i80FtctWK0QrJFppb5F_Yrpom5R298CtD8EB3oYn4CH6JMwk7sJekHKyJ46V-Twe2-NvCHkZuPJcK5VFrfIMDJ7MHA82c9IEo0VksePuPDhUk2PxfiqnacPtIoVVXtvEzlCH1uMe-Q5Doi2mtRJvz75mmDUKT1dTCo0NcrNgMJUDnstpudpjAXfFSMkS2VDB1Y47_YJZqQAbeHeHC4EcoRtQmij71_zM9SjJf6ad_bvkTvIX6W6v4HvkRt3cJ7cO0on4A_JrZJvGulmYtXO6Pdp7N6S2CfT3d5Mtamjw5FuAKaqXaVDkaDIaUvBUqe9pcSle_zptZpaGRMRJt68uf4x2Dz99GI8_Xl3-pF1mj-EbipwOLQCne91SmOVCCzCpw2vahXa5NkuR73MsC-3SzevMzZGREWXASY8ZPL6_Ktm3-5Ac74-PRpMsZWUAJcpikTmTe6Nj7h1XignJTXTMF1bktaq19tb4UKhoMXOMDiqPkZVBxyKIIkQk339ENpu2qR8TKjT0DXMEOsUFNGmiBHBIW8qaR2nMgLwC1VRnPe9G1a1XuKqSEitUYtUrcUD2UH0rUSTN7gra889VGoOVyi32UXoWovCFcAoTwlhAMThJuWcDsnWt_CqN5IvqL-4G5MWqGn4uHqzYpm6XKAOmDGl15ICUa6BZ69B6TTM76di8S8YBpPzJ_z_-lNxmuNJH3li9RTYX58v6GbhDC_e8w_wfybIPkw priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dahQxFA6lQumN-IurVSIIdsHRmUySTQSRdtyyiFsEu9C7IT-TdmU7o-su2Ls-hBf6Nj6BD9En8ZyZbHFBb4S5Sk5CyHeSnEzO-Q4hT3wuXa6kTIKSaQIbnkhs7k1ihfZa8cBCy905PpSjCX97LI43yCorapzAL3-92mE-qcl89vzr5_PXsOBfxYwkL-zZR6wCwDEgJ-ccA8uvMTga0cdrHO39dmvmQgvBIvvQP9puky2wMvAFEaPeQCDS-a_ZoOselH8cSQc3yPVoS9K9DvybZKOqb5GtcXwtv01-FqaujZ36aTOju8X-mz41tae_vulkUUGHp-cejq9OpkaRo1HRp2DFUtdR5lIMDTurp4b6SNJJdy8vvhd7hx_eDYfvLy9-0DbrR_8lRb6HBpSqbW4onIC-ARWq_DPaun3ZJole8TMs883SzqrEzpCtEWXAgA8JfK4Lo-z6vUMmB8OjYpTEjA0AsMgWidWp0yqkzuZSMi5yHSxzmeFpJSulnNHOZzIYzCqjvExDYAOvQuZ55gMS898lm3VTV_cI5QrGhvkDrcw5dKmDAMURZiCqPAite-QpQFN-6jg5yvYuk8sy4lkinmWHZ4_sI3xXokio3RY085Myrs9SpgbHKBzzgbuMW4nJYgxoOBhQqWM9srMCv1wpacmQ_I0pJXmPPL6qhsnFRxdTV80SZWCbQ8od0SODNaVZG9B6TT09bZm-BywHfc3v_3fLB2Sb4Q8CpJtVO2RzMV9WD8GKWthH7cr4DWZ-IYQ priority: 102 providerName: Scholars Portal |
Title | Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial |
URI | https://bmjopen.bmj.com/content/10/5/e034421.full https://www.proquest.com/docview/2433228864 https://search.proquest.com/docview/2405303885 https://pubmed.ncbi.nlm.nih.gov/PMC7239553 https://doaj.org/article/60a0e6e5c2df4c14b67eb6abec2220c2 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZ2FwlxQfyKwlIZCYmtRLaJY7sOtzZ0qRCtKuiicor8E7NFbbJa2gO3fQgO8DY8AQ-xT8JMkq62V6TIkeKJZWU-2-N45htCXrpY2lhJGXglwwAmPBGY2OnAiMQlinvmK-7O8USOTvn7uZjvEbGNhamc9q1ZHBfL1XGxOKt8K89Xtrv1E-tOx2mPxYkQcXef7MPye2OLXk2_XEAlaxiGolh2zeobpqICQGDATsw5w_wwYEngKSFGtoFAQ9m_Y2fuekneWHZO7pG7jb1I-3W_7pO9vHhAbo-bE_GH5E-qi0KbhVuUS3qUDt52qC4c_fszCdY5NHj2w8ESVcsUKDIbpR0Kliq1NS0uxfCvVbHQ1DVEnPTo6vJX2p98-jAcTq8uf9Mqs0fnDUVOhxKAU72uKaxyrgSY5O41rVy7TBk0nu9LfObKjVnmgVkiIyPKgJHuA7hsHSpZt_uInJ4MZ-koaLIygBJFtA5MEtpE-dCaWErGRZx4w2ykeZjLXCmrE-si6TVmjlFOht6znlM-cjxyHsn3H5ODoizyJ4RyBX3DHIFGxhyaTLwAcAjdE3nsRZK0yCtQTXZe825k1X4lllmjzwz1mdX6bJEBqu9aFEmzqwflxdesgU4mQ419FJY5z23EjcSEMBpQDEZSaFmLHG6VnzUj-XvGkOCNKSV5i7y4roaPiwcrusjLDcrAVIa0OqJFejug2enQbg2Au2LzbsD89L_ffEbuMPwJgJSy6pAcrC82-XOwlNamDeNj3oMy-TJrk1v9dDz-DPfBcDL92K7-PkD5bh5BOeaqXY2jf2qBIGk |
link.rule.ids | 230,314,727,780,784,864,885,2102,12056,21388,24318,27549,27550,27856,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793,73745,74302,77601,77619,77628,77632,77653 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbhMxELZoKgEXxK9IW8BISDQSq-6uf-LlgpqQKkASVZBKva38s6ZB6W5pkwO3PgQHeBuegIfokzCz6wZyQdqTPeu1dsbjsT3-PkJeOCYtU1JGXsk4AocnIsOcjozIXKa4T32N3TmeyOERf38sjsOG20VIq7z2ibWjdpXFPfK9FIG2UqUkf3P2NULWKDxdDRQaG2QTkdNFi2z2BpPDj6tdFghYMiHSADeUMLlnTr8gLxVYB97eYZwjSugGlAbQ_rVIcz1P8p-J5-AuuRMiRrrfqPgeuVGU98nNcTgTf0B-9XVZajNzs2pOd_u9tx2qS0d_f8-iRQENnnxzMEk1MiWKTIf9DoVYldoGGJfiBbDTcqapC1CcdPfq8kd_f_JpNBgcXl3-pDW3R-c1RVSHCkynfl1TmOdcBYZSuFe0Tu4yVRRy3-dY5qqlmReRmSMmI8pAmO4jeGxzWbJp9yE5OhhM-8Mo8DKAGkWyiEwW20z52BomZcoFy7xJbaJ5XMhCKasz6xLpNXLHKCdj79OuUz5xPHEe4fcfkVZZlcVjQrmCviFLoJGMQ5OZF2AeQndFwbzIsjZ5CarJzxrkjbxesTCZByXmqMS8UWKb9FB9K1GEza4LqvPPeRiFuYw19lHY1HluE24kUsJosGMIk2KbtsnOtfLzMJYv8r-W1ybPV9Xwc_FoRZdFtUQZcGYIrCPapLtmNGsdWq8pZyc1nnc3ZWCkbOv_H39Gbg2n41E-ejf5sE1up7juRxRZtUNai_Nl8QSCo4V5GkbAH0OOE-k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbhMxELZoKlVcEL8iUMBISDQSq-x6bcfLBTVpogBtFEEr9bbyz7oNSndLmxy49SE4wNvwBDxEn4SZXTeQC9KevLNea-fzzKw9_oaQVy6VNlVSRl7JOAKDJyKTOh0ZkblMcc98zd15MJHjI_7hWByH_KfLkFZ5YxNrQ-0qi2vkXYZEW0wpybs-pEVM90bvzr9GWEEKd1pDOY0NsgleMWYtstkfTqafVisuELxkQrBAPZSksmvOvmCNKkAKnuRJOUfG0A1oDQT-a1Hnes7kP05odJfcCdEj3W3UfY_cKsr7ZOsg7I8_IL8Guiy1mblZNac7g_5eh-rS0d_fs2hRQIen3xw4rEamRJHD8aBDIW6ltiHJpXgY7KycaeoCLSfdub76MdidfN4fDqfXVz9pXeej85Yiw0MFMKof1xR8nqsANIV7Q-tEL1NFIQ9-jm2uWpp5EZk58jOiDITsPoLLNgcnm34fkqPR8HAwjkKNBlCpSBaRyWKbKR9bk0rJuEgzb5hNNI8LWShldWZdIr3GOjLKydh71nPKJ44nziMV_yPSKquyeEwoVzA2rBhoZMqhy8wLgIrQPVGkXmRZm7wG1eTnDQtHXv-9pDIPSsxRiXmjxDbpo_pWokihXTdUFyd5mJG5jDWOUVjmPLcJNxLLw2jANIRMsWVtsn2j_DzM68v8Lwrb5OXqNnxc3GbRZVEtUQYMG5LsiDbprYFmbUDrd8rZac3t3WMpgDR98v-XvyBbAP58__3k41Nym-ESABLKqm3SWlwsi2cQJy3M8zAB_gDOuxgW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cannabidiol+%28CBD%29+and+%CE%949-tetrahydrocannabinol+%28THC%29+for+chronic+insomnia+disorder+%28%E2%80%98CANSLEEP%E2%80%99+trial%29%3A+protocol+for+a+randomised%2C+placebo-controlled%2C+double-blinded%2C+proof-of-concept+trial&rft.jtitle=BMJ+open&rft.au=Suraev%2C+Anastasia&rft.au=Grunstein%2C+Ronald+R&rft.au=Marshall%2C+Nathaniel+S&rft.au=D%27Rozario%2C+Angela+L&rft.series=Protocol&rft.date=2020-05-18&rft.pub=BMJ+Publishing+Group&rft.eissn=2044-6055&rft.volume=10&rft.issue=5&rft_id=info:doi/10.1136%2Fbmjopen-2019-034421&rft_id=info%3Apmid%2F32430450&rft.externalDBID=PMC7239553 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |